Alzheimer’s Disease and Marketing Death
By Nancy Valko An April, 2019 study in the Journal of the American Medical Association titled “Attitudes Toward Physician-Assisted Death From Individuals Who Learn They Have an Alzheimer Disease Biomarker” found that approximately 20% of cognitively normal older adults who had elevated beta-amyloid — a biomarker that is thought to increase the risk of Alzheimer’s …
Continue reading "Alzheimer’s Disease and Marketing Death"